Gmail Calendar Documents Reader Web more »
Help | Sign in
Go to Google Groups Home
  
Discussions for Sinovac Biotech Ltd. View all discussions

Message from discussion SVA New Dual Vaccine for Seasonal and H1N1 Flu
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
sakalas91  
View profile  
 More options Nov 6 2009, 7:28 am
From: sakalas91 <boris.baku...@gmail.com>
Date: Fri, 6 Nov 2009 04:28:23 -0800 (PST)
Local: Fri, Nov 6 2009 7:28 am
Subject: Re: SVA New Dual Vaccine for Seasonal and H1N1 Flu
Great news indeed, bluepeter!  Thanks!

H1N1 vaccine and common flu vaccine to merge
(chinadaily.com.cn)
Updated: 2009-11-06 15:18

Sinovac Biotech Co Ltd is doing research to merge the A(H1N1) flu
vaccine and traditional flu vaccine into one, qianlong.com reported
Friday.

Also, from an article entitled "Novartis Looking to Cut into H1N1
Vaccine Market in China"
Fri. November 06, 2009; Posted: 06:17 AM

The global vaccine market is expected to surge to EUR 18 billion in
2012, with influenza vaccine growing at the fastest pace, predicted
vaccine maker Sanofi Pasteur. Lehman Brothers Holdings Inc. (NYSE:
LEH) anticipated that global vaccine sales revenue would increase 18%
year by year, far exceeding an estimated 4.4% annual growth of the
entire pharmaceutical industry.

Looking ahead, Sinovac Biotech will launch more products to come up
with the mounting demand for H1N1 vaccine amid the lingering HIN1
pandemic influenza in the world, said Yin Weidong, chief executive
officer, chairman, and president for the company.

On Nov 6, 4:32 am, bluepeter <davidsbluebe...@googlemail.com> wrote:

> New big news of SVA putting seasonal flu and H1N1 vaccines together
> into a single vaccine to be launched next year. This new dual vaccine
> is really big news for SVA and its shareholders, and puts the Nasdaq
> listing (with possible fundraising) and quiet stakebuilding into
> perspective.
> The current share price will be remembered with a fondness in the next
> few years :-)


    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

Google Home - Terms of Service - Privacy Policy

©2010 Google